Morningstar
TOP NEWS: Bullish Convatec lifts guidance and predicts further growth
The London-based medical products and technologies company now expects 2024 organic sales growth of 7.25% to 8.0%, previously 6.0% to 7.0%. It projects a constant currency adjusted operating ...
43 minutes ago